New 1-(4-chloro-3-trifluoromethyl-phenyl)-3-(4-(pyridin-4-yloxy)-phenyl)-urea compounds useful to treat e.g. cancer, asthma, urticaria, arthritis, osteoarthritis, rheumatoid arthritis, sepsis, autoimmune diseases and multiple sclerosis

1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. 1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q) of formula (I) or (II), and their sa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: SCHEEFERS, HANS
Format: Patent
Sprache:eng ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. 1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q) of formula (I) or (II), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. R 1>F, Cl or CF 3; R 2>H or 1-4C-alkyl; and R 3>H, 1-4C-alkyl or OH. Independent claims are included for intermediates comprising 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-fluoro-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{3-chloro-4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-trifluoromethyl-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-trifluoromethyl-phenoxy}-pyridine-2-carboxylic acid, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-fluoro-phenoxy}-pyridine-2-carboxylic acid and 4-{3-chloro-4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid. [Image] [Image] ACTIVITY : Cytostatic; Antiinflammatory; Antiasthmatic; Antiallergic; Ophthalmological; Dermatological; Antiarthritic; Osteopathic; Antirheumatic; Antibacterial; Immunosuppressive; Antidiabetic; Hemostatic; Neuroprotective; Muscular-Gen.; Gastrointestinal-Gen.; Antipsoriatic; Nephrotropic; Respiratory-Gen.; Anabolic; Anorectic; Cardiant. MECHANISM OF ACTION : None given. Die vorliegende Patentanmeldung betrifft neue Pharmazeutika auf der Basis neuartiger Kinase-Inhibitoren, wie beispielsweise $F1.